NO20001847L - New use of compounds for anti-itch activity - Google Patents

New use of compounds for anti-itch activity

Info

Publication number: NO20001847L
Authority: NO; Norway
Prior art keywords: compounds; new use; itch activity; itch; activity
Prior art date: 1997-10-17

Application number

NO20001847A

Other languages

Norwegian (no)

Other versions

NO20001847D0 (en

Inventor

Don Edgar Griswold

Iv Siegfried Benja Christensen

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-17

Filing date

2000-04-10

Publication date

2000-04-10

2000-04-10 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2000-04-10 Publication of NO20001847L publication Critical patent/NO20001847L/en

2000-04-10 Publication of NO20001847D0 publication Critical patent/NO20001847D0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20001847A 1997-10-17 2000-04-10 New use of compounds for anti-itch activity NO20001847D0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6374697P	1997-10-17	1997-10-17
PCT/US1998/021886 WO1999020280A1 (en)	1997-10-17	1998-10-16	Novel use of compounds for anti-pruritic activity

Publications (2)

Publication Number	Publication Date
NO20001847L true NO20001847L (en)	2000-04-10
NO20001847D0 NO20001847D0 (en)	2000-04-10

Family

ID=22051225

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20001847A NO20001847D0 (en)	1997-10-17	2000-04-10	New use of compounds for anti-itch activity

Country Status (18)

Country	Link
EP (1)	EP1030666A4 (en)
JP (1)	JP2001520196A (en)
KR (1)	KR20010031149A (en)
CN (1)	CN1306426A (en)
AR (1)	AR015966A1 (en)
AU (1)	AU740875B2 (en)
BR (1)	BR9814080A (en)
CA (1)	CA2306985A1 (en)
CO (1)	CO4810374A1 (en)
CZ (1)	CZ20001376A3 (en)
HU (1)	HUP0003792A3 (en)
IL (1)	IL135581A0 (en)
NO (1)	NO20001847D0 (en)
NZ (1)	NZ503551A (en)
PL (1)	PL341062A1 (en)
TR (1)	TR200001040T2 (en)
WO (1)	WO1999020280A1 (en)
ZA (1)	ZA989450B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ20031895A3 (en)	2001-01-31	2004-08-18	Pfizeráproductsáinc	Nicotinamide biaryl derivatives useful as PDE4 isozyme inhibitors
US7250518B2 (en)	2001-01-31	2007-07-31	Pfizer Inc.	Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
PL365443A1 (en)	2001-01-31	2005-01-10	Pfizer Products Inc.	Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
SK8942003A3 (en)	2001-01-31	2004-10-05	Pfizer Prod Inc	Ether derivatives useful as inhibitors
US20030175314A1 (en) *	2001-11-19	2003-09-18	Didriksen Erik Johannes	Pharmaceutical composition for dermal application
TW200503709A (en) *	2003-07-17	2005-02-01	Santen Pharmaceutical Co Ltd	Itching treating agent containing piperidine derivative as active ingredient
WO2005053672A1 (en) *	2003-12-04	2005-06-16	Santen Pharmaceutical Co., Ltd.	Remedy for pruritus comprising cilomilast or salt thereof as the active ingredient
JP2005187458A (en) *	2003-12-04	2005-07-14	Santen Pharmaceut Co Ltd	Itchiness-treating agent consisting of cilomilast or its salt as active ingredient
EP1781657B1 (en)	2004-02-14	2013-03-27	GlaxoSmithKline Intellectual Property Development Limited	Medicaments with hm74a receptor activity
JP2008137892A (en) *	2005-03-04	2008-06-19	Eisai Co Ltd	Antipruritic agent
WO2007017261A1 (en)	2005-08-10	2007-02-15	Smithkline Beecham Corporation	Xanthine derivatives as selective hm74a agonists
PL1992622T3 (en)	2006-02-21	2012-01-31	Eisai R&D Man Co Ltd	4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
TWI404709B (en) *	2006-02-21	2013-08-11	Eisai R&D Man Co Ltd	4-(3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
CA2678477A1 (en)	2007-02-16	2008-08-21	Eisai R&D Management Co., Ltd.	Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
JP5060561B2 (en)	2007-08-17	2012-10-31	エーザイ・アール・アンド・ディー・マネジメント株式会社	New topical preparation
KR20100042245A (en)	2007-08-17	2010-04-23	에자이 알앤드디 매니지먼트 가부시키가이샤	Method for producing quinazoline derivative
EP2727594B1 (en) *	2011-06-28	2017-12-20	Mitsubishi Tanabe Pharma Corporation	Naphtalene compounds to treat itch
BR112017016065A2 (en)	2015-01-30	2018-04-03	Shanton Pharma Co., Ltd.	prevention or treatment of uric acid or gouty disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR930703319A (en) *	1990-12-21	1993-11-29	데이빗 로버츠	Chianthine derivatives
ES2184077T3 (en) *	1996-03-26	2003-04-01	Altana Pharma Ag	NEW FENANTRIDINS REPLACED IN POSITION 6.
JP2000510134A (en) *	1996-05-15	2000-08-08	ビイクグルデンロンベルクヒェーミッシェファブリークゲゼルシャフトミットベシュレンクテルハフツング	New imidazopyridine
JP2001514640A (en) *	1997-03-07	2001-09-11	ビイクグルデンロンベルクヒエーミツシエフアブリークゲゼルシヤフトミツトベシユレンクテルハフツング	New tetrazole
JP2002504091A (en) *	1997-03-18	2002-02-05	ベーアーエスエフアクツィエンゲゼルシャフト	Methods and compositions for modulating responsiveness to corticosteroids
SI0988302T1 (en) *	1997-06-03	2003-08-31	Altana Pharma Ag	Benzonaphthyridines

1998
- 1998-10-15 AR ARP980105131A patent/AR015966A1/en not_active Application Discontinuation
- 1998-10-16 IL IL13558198A patent/IL135581A0/en unknown
- 1998-10-16 EP EP98953608A patent/EP1030666A4/en not_active Withdrawn
- 1998-10-16 CO CO98060225A patent/CO4810374A1/en unknown
- 1998-10-16 HU HU0003792A patent/HUP0003792A3/en unknown
- 1998-10-16 CZ CZ20001376A patent/CZ20001376A3/en unknown
- 1998-10-16 TR TR2000/01040T patent/TR200001040T2/en unknown
- 1998-10-16 ZA ZA989450A patent/ZA989450B/en unknown
- 1998-10-16 BR BR9814080-9A patent/BR9814080A/en not_active IP Right Cessation
- 1998-10-16 KR KR1020007004053A patent/KR20010031149A/en not_active Withdrawn
- 1998-10-16 AU AU10938/99A patent/AU740875B2/en not_active Ceased
- 1998-10-16 WO PCT/US1998/021886 patent/WO1999020280A1/en not_active Ceased
- 1998-10-16 JP JP2000516677A patent/JP2001520196A/en not_active Withdrawn
- 1998-10-16 NZ NZ503551A patent/NZ503551A/en unknown
- 1998-10-16 CN CN98810066A patent/CN1306426A/en active Pending
- 1998-10-16 CA CA002306985A patent/CA2306985A1/en not_active Abandoned
- 1998-10-16 PL PL98341062A patent/PL341062A1/en unknown
2000
- 2000-04-10 NO NO20001847A patent/NO20001847D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0003792A3 (en)	2001-12-28
KR20010031149A (en)	2001-04-16
JP2001520196A (en)	2001-10-30
CO4810374A1 (en)	1999-06-30
NZ503551A (en)	2002-05-31
CA2306985A1 (en)	1999-04-29
NO20001847D0 (en)	2000-04-10
IL135581A0 (en)	2001-05-20
CZ20001376A3 (en)	2002-06-12
HUP0003792A2 (en)	2001-10-28
EP1030666A4 (en)	2002-10-16
AU1093899A (en)	1999-05-10
PL341062A1 (en)	2001-03-26
BR9814080A (en)	2000-09-26
WO1999020280A1 (en)	1999-04-29
TR200001040T2 (en)	2001-01-22
AU740875B2 (en)	2001-11-15
AR015966A1 (en)	2001-05-30
ZA989450B (en)	1999-04-19
CN1306426A (en)	2001-08-01
EP1030666A1 (en)	2000-08-30

Publication	Publication Date	Title
CY2012029I2 (en)	2015-08-05	NEW FORM OF 5-OMEPRAZOLE
EE200000044A (en)	2000-10-16	New compounds
PT996622E (en)	2003-01-31	NEW ESPEROAZABICICLIC HETEROCYCLIC COMPOUNDS
ID24638A (en)	2000-07-27	COMPOUNDS OF ANTI ARYTHMIA BISPIDINA
NO20015855L (en)	2002-01-30	New use of compounds as antibacterial agents
NO20001847L (en)	2000-04-10	New use of compounds for anti-itch activity
ID22878A (en)	1999-12-16	ACTIVE COMPOSITION THERAPY
NO993298L (en)	1999-07-02	New procedure
ID29966A (en)	2001-10-25	SULFONYLOKSAZOLAMINA-SULFONYLOKSAZOLAMINA AS ACTIVE COMPOUNDS OF THERAPY
ID24677A (en)	2000-07-27	COMBINATION OF FUNICIDAL ACTIVE COMPOUNDS
NO995796L (en)	1999-11-26	New procedure
ID24270A (en)	2000-07-13	REMOVAL OF KERATOTIC CONSTITIONS
FI963531A0 (en)	1996-09-09	New use of quinoline-3-carboxamide compounds
NO996438D0 (en)	1999-12-23	New combination of asthma drugs
FI963532A0 (en)	1996-09-09	New use of quinoline-3-carboxamide compounds
ID23437A (en)	2000-04-20	REMOVAL OF KERATOTIC CONSTITIONS
ID24694A (en)	2000-08-03	USAGE OF SUBSTANCE AS CATALYST FOR THE MAKING OF CAPROLAKTAM
ID24439A (en)	2000-07-20	USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
ID24521A (en)	2000-07-20	USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
ID19787A (en)	1998-07-30	COMPOUND 25-HYDROXY-16-ENA-26,27-BISHOMO-COLLECTION OF FERROL
NO963762D0 (en)	1996-09-09	New use of quinoline-3-carboxamide compounds
NO963764D0 (en)	1996-09-09	New use of quinoline-3-carboxamide compounds
SE9704838D0 (en)	1997-12-22	New compounds
SE9702535D0 (en)	1997-07-01	New compounds
SE9704839D0 (en)	1997-12-22	New compounds

Legal Events

Date	Code	Title	Description
2004-10-18	FC2A	Withdrawal, rejection or dismissal of laid open patent application